Frontotemporal Dementia

Frontotemporal dementia (FTD) refers to disorders caused by progressive neuronal loss in the frontal and temporal lobes of the brain. Here is the latest research on FTD and FTD-associated disorders.

July 30, 2020

Value of the Frontal Assessment Battery Tool for Assessing the Frontal Lobe Function in Stroke Patients

Annals of Rehabilitation Medicine
Mihyang HanMin-Wook Kim
July 17, 2020

Autophagy and Alzheimer's Disease

Advances in Experimental Medicine and Biology
Sheng ChenWeidong Le
July 18, 2020

Automated Analysis of Natural Speech in Amyotrophic Lateral Sclerosis Spectrum Disorders

Neurology
Naomi NevlerMurray Grossman
August 1, 2020

A Lack of Practice Effects on Memory Tasks Predicts Conversion to Alzheimer Disease in Patients With Amnestic Mild Cognitive Impairment

Journal of Geriatric Psychiatry and Neurology
Maria Stefania De SimoneGiovanni Augusto Carlesimo
July 22, 2020
Open Access

Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS/FTD mice

Proceedings of the National Academy of Sciences of the United States of America
Tao ZuLaura P W Ranum
July 21, 2020
Open Access

Praja1 RING-finger E3 ubiquitin ligase suppresses neuronal cytoplasmic TDP-43 aggregate formation

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Kazuhiko WatabeNoriyuki Shibata
July 30, 2020
Review
Open Access

Young onset dementia

Der Nervenarzt
Matthias PawlowskiThomas Duning
July 18, 2020

Viral Delivery of Non-Mutated Human Truncated Tau to Neurons Recapitulates Key Features of Human Tauopathy in Wild-Type Mice

Journal of Alzheimer's Disease : JAD
Thomas VogelsTomáš Hromádka
July 22, 2020
Open Access

Lysine acetylation regulates the RNA binding, subcellular localization and inclusion formation of FUS

Human Molecular Genetics
Alexandra ArenasHaining Zhu
July 17, 2020
Open Access

Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration

Alzheimer's Research & Therapy
C M HoltonK A Wafford
July 17, 2020
Open Access

18F-MK-6240 PET for early and late detection of neurofibrillary tangles

Brain : a Journal of Neurology
Tharick A PascoalPedro Rosa-Neto
July 22, 2020

The protein-surfactant stoichiometry governs the conformational switching and amyloid nucleation kinetics of tau K18

European Biophysics Journal : EBJ
Jaspreet KaurMily Bhattacharya
July 17, 2020

The relationship of parental longevity with the aging brain-results from UK Biobank

GeroScience
Qu TianLuigi Ferrucci
July 19, 2020
Review
Open Access

Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders

Cells
Sujay PaulAshutosh Sharma
July 31, 2020
Open Access

Modeling of Frontotemporal Dementia Using iPSC Technology

International Journal of Molecular Sciences
Minchul KimJihwan Song

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/frontotemporal-dementia/806b2e01-8987-48ff-a599-f71effb4d394